Gynica Healthcare

The The National Academies of Sciences, Engineering, and Medicine report highlights a decades-long lack of prioritization and funding for women’s health research at the The National Institutes of Health. It calls for creating a dedicated institute and allocating nearly $16 billion over five years to address gaps, including conditions like #endometriosis, #lupus, and #menopause-related issues. This transformative proposal aims to elevate research into female-specific health disparities, improve inclusion, and foster innovation across #NIH initiatives. The message is clear: women’s health must be a national priority. At Gynica, we echo this call for action and believe that increasing funding and advancing research will create a healthier future for all. #WomensHealth #ResearchMatters #HealthEquity https://lnkd.in/eJgMQcCV

Join our CEO, Yotam Hod, at the Women in Tech® Israel Annual Summit! This year’s theme is women’s health, well-being, and the rapidly growing $117 billion FemTech industry. Health, opportunity, and prosperity are not just women’s issues—they’re essential to a better society and thriving economy. He'll be speaking about how innovation demands courage to challenge stigmas and transform lives. What to Expect: Join us for a unique summit to learn, connect, and innovate! Featuring top VCs, a startup showcase, inspiring talks by changemakers, networking opportunities, exclusive perks for women in tech, a movement break, and immersive experiences exploring women’s health, and much more. Don’t miss your chance to be part of this conversation! 25% discount on tickets with promo code (NIS 90, regular price NIS 120) Register [https://lnkd.in/dN7VfiCR] Sponsors Herzog Law Firm P.C., Maccabi Health care Services, eHealthVentures, FINN Partners, Pitango, Vichy Laboratoires Community Partners FemTech Israel - Technology & Innovation for Women, iKare Innovation, Impact51, ScienceAbroad, Yazamiyot - Women Entrepreneurs, mHealthIL, Merit Spread Foundation, and many more. Speaker lineup Anne BAER, WIT Chapter Director Keren Schachter, GM @ Maccabi Enterprises Merav Weinryb, Founder @ Sunvest Capital Partners Liat Sverdlov, Partner @ OurCrowd Anya Eldan, Partner @ Edge Ventures Hila Karah, Partner @ Pitango Health VC Orly Sternfeld @ eHealth Ventures VC Cecile Blilious, Impact Partner @ Pitango VC Orli Gal, High Tech Partner @ Herzog, Fox & Neeman Law Shelly Bloch, Founder @FemtechIL Ellie Gorlin Hanson, Health Tech Partner @ Finn Partners Michal Shalem, Founder @ Impact.51 Femtech Ventures Melissa Lax, EMBA, WIT Event Director Rinat Levi, Change Maker & WIT Volunteer And many more… Event Details:  Location: Herzog Law Firm, Yitzhak Sadeh St. 6, Tel Aviv  Date: Thursday, Nov. 21, 2024  Time: 9:00 AM - 2:00 PM Come, connect, learn, and innovate!

A new report from the NHS suggests that menstrual pain and endometriosis are costing the UK economy €13 billion annually in lost productivity. At Gynica, we're working to change these statistics. This report reinforces what we've long known - investing in women's health isn't just about wellbeing, it's an economic imperative. Through our innovative research and development, we're committed to finding effective solutions for conditions like endometriosis that significantly impact women's daily lives and productivity. It's time to prioritize women's health - not just for individual wellness, but for our collective economic future. #WomensHealth #Endometriosis #Healthcare #Innovation #FemTech #Research https://lnkd.in/d5xdBqpR

The Lancet Highlights Urgent Need for Endometriosis Innovation 🚨 A recent editorial in The Lancet sheds light on the critical challenges facing endometriosis care and research. As a company dedicated to revolutionizing endometriosis treatment, we at #Gynica find these insights both alarming and motivating. The editorial emphasizes that "no amount of medical innovation will change outcomes if women are prevented from accessing care", and we couldn't agree more. We believe that by combining innovative science with improved access and awareness, we can make a real difference in the lives of millions of women worldwide. #Endometriosis #WomensHealth #MedicalInnovation #Gynica https://lnkd.in/dF3MTxis

New research published in the Journal of Clinical Medicine (JCM) MDPI further strengthens the link between the endocannabinoid system (ECS) and gut microbiota in the development and progression of endometriosis. The study suggests that cannabinoids show great promise as a new therapeutic approach. The study concludes that both the ECS and the gut microbiota could be potential targets for therapeutic interventions in endometriosis. While further research is needed, this study offers a glimmer of hope for those suffering from this debilitating condition. We applaud the team from Australia, led by A/Prof Mike Armour, for their work in this field. At Gynica, we're committed to staying at the forefront of research and development in women's health, and we're excited to see how this research progresses. #endometriosis #cannabinoids #womenshealth #research #ECS

We are thrilled to share that #Gynica is a proud supporter and co-founding partner of the  𝗳𝗶𝗿𝘀𝘁-𝗲𝘃𝗲𝗿 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗰 #𝗙𝗲𝗺𝗧𝗲𝗰𝗵 𝗰𝗼𝘂𝗿𝘀𝗲 𝗶𝗻 𝗜𝘀𝗿𝗮𝗲𝗹, launching next semester at Shenkar - Engineering. Design. Art. This groundbreaking course, has received official approval from the National Council for Higher Education, offering students 4 academic credits as part of their studies. At Gynica, we are dedicated to advancing FemTech and empowering future leaders in our field. This course represents a major step forward, and we are excited to contribute to shaping the future of FemTech education. If you’re interested in learning more or hosting an intern from this innovative program, check out the details and register here: https://bit.ly/3ZfzQP2. Let’s drive the future of FemTech together! #FemTech #Innovation #Education #Shenkar #STEP #Gynica #Empowerment #FutureOfTech Yotam Hod Shelly Bloch FemTech Israel - Technology & Innovation for Women

Exciting new research published in Nature Magazine's NPJ Women's Health journal demonstrates the promising potential of cannabinoids for alleviating menstrual & #endometriosis-related symptoms and improving quality of life. Key findings from the study on cannabinoids-based vaginal suppositories: - Alleviated a range of menstrual-related symptoms - Improved daily functioning - Reduced use of analgesics - Showed potential dose-dependent response As a company developing cannabinoid-based treatments for endometriosis, we're encouraged to see growing evidence supporting the efficacy of these compounds for gynecological conditions. This research aligns with our mission to provide innovative solutions that can significantly enhance the lives of women suffering from endometriosis and other reproductive health issues. Read the full study here: https://lnkd.in/dsz3TG_9 We would like to congratulate our allies from Foria and Dr. Staci A. Gruber on this publication!

Olympic medalist Brittany Brown's inspiring story highlights the challenges faced by women with #endometriosis. We are inspired by Brown's courage in raising awareness after winning a bronze medal in the 200m at #Paris2024. Her victory underscores the urgent need for innovative treatments, such as Gynica's #IntraVag© solution.

Gynica is pleased to have been included in the recent report from FemHealth Insights on uterine health. The report highlights a median exit return of 8.2x for companies in this sector, underscoring the growing interest in innovative treatments for conditions like endometriosis. As developers of solutions for endometriosis, we're committed to advancing care in this crucial area of women's health. For more insights: https://loom.ly/dVFvzkE #Endometriosis #WomensHealth #FemTech

Gynica Healthcare is proud to announce that our CEO, Yotam Hod, will be representing the company and presenting at the prestigious inaugural Women's Health Therapeutics & Diagnostics Summit hosted by Hanson Wade Group in Boston, MA on July 23-25, 2024. At this summit, Yotam will showcase Gynica's pioneering research into the potential of cannabinoids for treating endometriosis and other critical women's health conditions. This summit unites leaders from top pharma and biotech companies like Organon, Ferring Pharmaceuticals, Hera Biotech, Daré Bioscience, Inc., Evvy, Heranova Lifesciences, and NextGen Jane, Inc. to drive innovation and improve clinical outcomes for women worldwide. We're honored for Gynica to contribute our expertise alongside this esteemed group, all striving to bridge major gaps in women's health through novel diagnostics and therapeutics. For more details: https://lnkd.in/dC-6AksU Tom Angus Kiran Thomson Rashi Taunk Molly Mahiques